Blood Pressure, High
Conditions
Keywords
goal setting
Brief summary
SMART goal setting is a patient-led method that can help improve execution and facilitate behavioral changes. Functions such as diet tracking, interaction, and feedback in smartphone application may help enhance patient compliance. This study aims to explore the nutrition intervention measures of SMART goal setting combined with smartphone applications for daily self-management on the effect of improving diet quality of people with high blood pressure.
Interventions
BEHAVIORALGoal setting with mobile-based self-management tool
In addition to the nutrition education provided to both groups, the participants of the intervention group will work with the dietitian to make behavior-change goals based on SMART goal setting strategy. They will also have access to diet tracking function and weekly report on smart phone application. The dietitian will also meet with the participants virtually to track their progress and provide suggestions.
OTHERNutrition education
The control group will receive nutrition education about blood pressure management by the dietitian
Sponsors
China National Center for Cardiovascular Diseases
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Age 20-70; * Hypertension diagnosis, or high blood pressure (SBP between 120-139 mmHg and/or DBP between 80-89 mmHg); * Eating an unhealthy diet (estimated DASH score \< 6) ; * Owning a smartphone and able to operate it proficiently; * Sign the informed consent.
Exclusion criteria
* Severe cardiovascular and respiratory diseases, such as acute myocardial infarction, tachyarrhythmia, pulmonary edema, and severe aortic stenosis; * Acute phase of cardiovascular and cerebrovascular diseases; * Uncontrolled blood pressure; * Diagnosed mental diseases or epilepsy; * Cardiac pacemaker implantation; * Allergic constitutions; * Pregnant women or planning to become pregnant; * Individuals who have participated in other clinical studies within the past 3 months; * Refuse to sign the informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diet quality | From enrollment to the end of treatment at 12 weeks | Diet quality is measured by the DASH Score that includes eight dietary components to reflect the adherence to the DASH dietary pattern. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Body Weight | From enrollment to the end of treatment at 12 weeks | Body weight will be measured by the bioelectrical impedance analysis. |
| Blood pressure | From enrollment to the end of treatment at 12 weeks | Blood pressure will be measured at baseline visit and the follow-up visit after the 12-week intervention. Blood pressure will be measured using calibrated electronic blood pressure monitor. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Sleep Quality | From enrollment to the end of treatment at 12 weeks | Sleep quality will be measured by the Pittsburgh Sleep Quality Index |
| Depression | From enrollment to the end of treatment at 12 weeks | Depressive status will be measured by the Patient Health Questionnaire-9 |
| Anxiety | From enrollment to the end of treatment at 12 weeks | Anxiety status will be measured by the Generalized Anxiety Disorder-7. |
Countries
China
Contacts
Primary ContactXuezhu Sun
Outcome results
None listed